Novosanis Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 20

Employees

  • Latest Deal Type
  • M&A

Novosanis General Information

Description

Developer of medical devices designed to improve the quality of diagnostics tests as well as the accuracy of drug delivery. The company's devices range from injection appliances to in vitro diagnostic accessories that are suited for the collection of first void urine which provides an improved diagnosis of sexually transmitted infections and cancer, thereby helping physicians to treat the patients.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Medical Supplies
Other Industries
Other Devices and Supplies
Parent Company
Corporate Office
  • Bijkhoevelaan 32c
  • 2110 Wijnegem
  • Belgium
+32 03 000 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Novosanis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Merger/Acquisition 04-Jan-2019 00.000 Completed Generating Revenue
7. Angel (individual) 10-Jul-2018 00.000 00.000 00.000 Completed Generating Revenue
6. Grant 04-Apr-2017 00.000 Completed Generating Revenue
5. Angel (individual) 26-Jan-2017 00000 00.000 00.000 Completed Generating Revenue
4. Grant 15-Sep-2015 00000 Completed Generating Revenue
3. Grant 13-Aug-2014 00000 00000 Completed Generating Revenue
2. Seed Round 19-Jul-2013 $636K $636K 00.000 Completed Generating Revenue
1. Spin-Off 12-Mar-2013 Completed Startup
To view Novosanis’s complete valuation and funding history, request access »

Novosanis Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Class B 00,000 000.00 000.00 00 000.00 0.000
Class A 00,000 000.00 000.00 00 000.00 0.000
Class B 0,000 000.00 000.00 00 000.00 0.000
Class A 0,000 000.00 000.00 00 000.00 0.000
Class B 0,000 000.0 000.0 00 000.0 0.000
Class A 000 000.0 000.0 00 000.0 0.000
Class B 00,000 000.00 000.00 00 000.00 0.00
Class A 0,000 000.00 000.00 00 000.00 0.000
Class B 18,000 $24.97 $24.97 1x $24.97 8.82%
Class B 20,000 $28.43 $28.43 1x $28.43 9.8%
To view Novosanis’s complete cap table history, request access »

Novosanis Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of medical devices designed to improve the quality of diagnostics tests as well as the accuracy of drug delive
Medical Supplies
Wijnegem, Belgium
20 As of 2023
00.000
000000&0 00.000

000000

amco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in r
0000000000 000000000
Saint Louis, MO
00 As of 0000
000.00
0000000000.

000000

tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, qu
0000000000 000000000
Puteaux, France
000 As of 0000
000.00
0000 0000-00-00
000000&0
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Novosanis Competitors (10)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
BacterioScan Formerly VC-backed Saint Louis, MO 00 000.00 0000000000.
ELITechGroup Private Equity-Backed Puteaux, France 000 000.00 000000&0
Lightpoint Medical Formerly VC-backed Amersham, United Kingdom 00 000.00 000000&0 000.00
Accelerate Diagnostics Corporation Tucson, AZ 000 000.00 00000000 000.00
Mindera Health Venture Capital-Backed San Diego, CA 00 0000 00000000000 0000
You’re viewing 5 of 10 competitors. Get the full list »

Novosanis Patents

Novosanis Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4045114-A1 Needle adaptor and assembly for forming an injection device for administering a fluid to a subject Pending 16-Oct-2019 00000000
JP-2022552866-A Needle adapter and assembly for forming an injection device for administering fluid to a subject Pending 16-Oct-2019 00000000
AU-2020368005-A1 Needle adaptor and assembly for forming an injection device for administering a fluid to a subject Pending 16-Oct-2019 00000000
CA-3158194-A1 Needle adaptor and assembly for forming an injection device for administering a fluid to a subject Pending 16-Oct-2019 00000000
CA-3157268-A1 Small volume liquid sampler Pending 07-Oct-2019 A61B10/007
To view Novosanis’s complete patent history, request access »

Novosanis Executive Team (8)

Name Title Board Seat Contact Info
Kathleen Weber President & Chairman
Alex Vorsters Ph.D Scientific Advisor & Member of Scientific Advisory Board
Joris Noreillie Chief Financial Officer
Koen Beyers Co-Founder, Chief Technology Officer & Board Member
Vanessa Vankerckhoven Ph.D Founder
You’re viewing 5 of 8 executive team members. Get the full list »

Novosanis Board Members (7)

Name Representing Role Since
Kathleen Weber Novosanis President & Chairman 000 0000
Koen Beyers Self Co-Founder, Chief Technology Officer & Board Member 000 0000
Luc Kindt Self Board Member & Advisor, Sales 000 0000
You’re viewing 3 of 7 board members. Get the full list »

Novosanis Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Novosanis Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Horizon 2020 SME Instrument Government Minority 000 0000 000000 0
Taste Westerlund Family Office Minority 000 0000 000000 0
To view Novosanis’s complete investors history, request access »

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »